Fusion Pharmaceuticals Inc. (FUSN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus...
Source LinkFusion Pharmaceuticals Inc. (FUSN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus...
Source Link
Comments